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Objectives: Our main objective was to biologically improve rotator cuff healing in an elderly rat model using
mesenchymal stem cells (MSCs) in combination with a collagen membrane and compared against other
current techniques.
Methods: A chronic rotator cuff tear injury model was developed by unilaterally detaching the supraspinatus
(SP) tendons of Sprague-Dawley rats. At 1 month postinjury, the tears were repaired using one of the following
techniques: (a) classical surgery using sutures (n = 12), (b) type I collagen membranes (n = 15), and (c) type I
collagen membranes + 1 × 106 allogeneic MSCs (n = 14). Lesion restoration was evaluated at 1, 2, and 3 months
postinjury based on biomechanical criteria. Continuous variables were described using mean and standard
deviation (SD). To analyse the effect of the different surgical treatments in the repaired tendons’ biomechanical
capabilities (maximum load, stiffness, and deformity), a two-way ANOVA model was used, introducing an
interaction between such factor and time (1, 2, and 3 months postinjury).
Results: With regard to maximum load, we observed an almost significant interaction between treatment and
time (F = 2.62, df = 4, p = 0.053). When we analysed how this biomechanical capability changed with time for
each treatment, we observed that repair with OrthADAPT and MSCs was associated with a significant increase
in maximum load (p = 0.04) between months 1 and 3. On the other hand, when we compared the different
treatments among themselves at different time points, we observed that the repair with OrthADAPT and MSCs
has associated with a significant higher maximum load, when compared with the use of suture, but only at
3 months (p = 0.014). With regard to stiffness and deformity, no significant interaction was observed (F = 1.68,
df = 4, p = 0.18; F = 0.40, df = 4, p = 0.81; respectively).
Conclusions: The implantation of MSCs along with a collagen I scaffold into surgically created tendon defects
is safe and effective. MSCs improved the tendon’s maximum load over time, indicating that MSCs could help
facilitate the dynamic process of tendon repair.
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The rotator cuff is formed by a group of muscles and ten-
dons that stabilise the glenohumeral joint and enable the
normal movement of the shoulder. Rotator cuff tears can
occur due to traumatic injury, but most occur as a result
of the gradual degeneration of the tendon. Consequently,
elderly individuals are often affected in a chronic manner.
Partial and/or full thickness tears in the rotator cuff ten-
dons are common causes of pain and disability of the
shoulder and can ultimately lead to osteoarthritis.
The surgical procedures that are typically used to treat
these lesions, which use sutures to reattach the torn
tendons to the bone, are unreliable, and lesion reoccur-
rence is very frequent reaching more than 50 % [1]. Due
to the weakness of the fibres in the affected tendon, pri-
marily the supraspinatus (SP) tendon, at its insertion
site, it is very difficult to correctly reattach the tendon
during surgery [2]. Clinical failure in degenerative lesions
has been linked to preoperative factors such as age [3],
reduced acromiohumeral distance [4], tear size [5–8],
chronically inferior tissue quality and tendon retraction
and to surgical factors such as high repair tension [9].
All of these factors have a marked effect on biological
healing and remodelling, which eventually influence the
clinical outcome. When full-thickness tears occur in the
elderly, in whom the natural healing ability is greatly
reduced, it is crucial to reduce the in vivo mechanical
forces that work against tendon repair during postopera-
tive healing and to enhance natural healing, thereby
preventing tendon re-ruptures and eventually resulting
in a better clinical outcome. Therefore, there is a need
for new approaches that improve the healing process
through mechanical re-enforcement and enhance natural
healing, especially at the insertion site. In this context,
different therapies in the field of tendon regeneration,
such as the local injection of mesenchymal stem cells
(MSCs) and growth factors or tissue engineering using
bioactive biological membranes, have been tested in
different animal models [10–16]. These approaches have
been reported to improve tendon repair, although the
complete regeneration of the tendon has never been
achieved. Although the research in this field is intense,
the majority of studies have focused on the treatment of
traumatic injuries, especially in young animals, in which
the muscle and tendon are not as degraded as the tissue
in chronic lesions [17]. As a result of these differences,
these animal studies report better outcomes than are
likely to occur in humans. In the current study, we
developed and validated a massive chronic rotator cuff
tear rat model to explore different repair strategies. We
compared three different strategies: a surgical procedure
based on a modified Masson-Allen stitch using a suture, a
surgical procedure using a commercially available biocom-
posite scaffold consisting of type I collagen that is availablefor human use and a surgical procedure using the type I
collagen scaffold in combination with allogeneic MSCs.Materials and methods
Study design
Sprague-Dawley rats (9 months old) were included in this
study. The three therapeutic approaches were performed
1 month postdetachment of the SP tendon and are de-
scribed as follows: (a) a surgical procedure based on a
modified Masson-Allen stitch using a suture (6/0 prolene;
n = 12), (b) a surgical procedure using a 0.5-mm-thick
commercial type I collagen membrane (OrthADAPT®
Bioimplant, Penta Biomedical® S.r.l., Verona, Italy; n = 15)
and (c) a surgical procedure using the type I collagen
membrane seeded with 1 × 106 MSCs (n = 14).Validation of experimental rat model of chronic rotator
cuff tears
To generate chronic rotator tears in the animal model, a
tear was surgically created in one of the shoulders by
sharply detaching the SP tendon from its insertion site.
While adhering to aseptic operating room protocols, the
deltoid muscle was subsequently detached sharply from the
acromion. The SP was visualised and then exposed by
external rotation of the humerus, and it was detached
sharply at the bone insertion site. The end of the tendon
was marked with a suture (5/0 prolene) with a long tail.
The fibrocartilage was removed from the insertion site with
a scalpel blade, and the SP tendon was allowed to freely
retract. The overlying deltoid muscle and skin were then
closed (Fig. 1). Rats were sacrificed at months 1 (n = 16), 2
(n = 13), and 3 (n = 12) postinjury, and specimens (humerus
and scapula) were harvested. Recovery was evaluated
through biomechanical evaluations. Animal care was
performed in accordance with institution guidelines. The
approval was given by the Ethics Committee of the Hospital
Clinico San Carlos.Different approaches for the repair chronic rotator cuff
tears in the rat model
One month after the injury, one of three different add-
itional surgeries was performed to repair the tears: (a) the
typical surgical procedure using a suture (6/0 prolene), (b)
a surgical procedure using a 0.5-mm-thick commercial type
I collagen membrane (OrthADAPT®Bioimplant, Penta Bio-
medical® S.r.l., Verona, Italy), and (c) a surgical procedure
using a type I collagen membrane seeded with 1 × 106
MSCs. Scar tissue from the first surgery was removed be-
fore the second surgical procedure was performed. The rats
were sacrificed at 1, 2, and 3 months postinjury, and speci-
mens (humerus and scapula) were harvested. Recovery was
evaluated at the time of sacrifice by biomechanical analyses.
Fig. 1 Representative image of established chronic supraspinatus lesion. Black arrows represent the tendon-bone interface. a Gap is clearly observed in
b magnification ×125. a Normal tendon. b Injured tendon
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preparation
MSCs were obtained from the femoral channel of age-
matched rats (9 months old) prior to the study. The
cells were placed in 100-mm dishes, and the cultures
were maintained for 48 h under standard conditions.
MSCs adhered to the plates and proliferated to form
colonies. When the cultures reached confluence, the
MSC colonies that adhered to the plate were detached
using 0.25 % Trypsin-EDTA (Gibco BRL Life Tech-
nologies, Carlsbad, CA, USA). The cells were counted,
and their viability was determined using the Trypan
blue exclusion method. Aliquots containing 1 × 106
cells were suspended in 200 μl of saline. OrthADAPT
membranes were placed on the cell suspension con-
taining 1 × 106 cells MSCs within 15 min before the
event of surgical procedure. Previously, we have estab-
lished that 5 min is the time the cells need in order to
be adherent on the surface. No MSCs were observed
in the remaining saline liquid.
Biomechanical analysis
Specimens (humerus and scapula) were dissected and
stored at −20 °C until analysis. For the mechanical test-
ing, both sides of the tendon (humerus and scapula)
were wrapped tightly with elastic rubber to prevent the
sample from slipping out of the tube during the tensile
test. For additional support, the rubber was fixed to the
sample smear on both ends with the use of superglue.
The tendons were wrapped in gauze and moistened with
physiological serum to protect them. Two sets of tubes
were prepared for the attachment of the samples to ten-
sile machine grips: smaller tubes made of silicone
(15 mm diameter) for the humerus and larger tubes
made of polypropylene (25 mm diameter) for the scap-
ula. One end of each tube was sealed with a piece of foil
to prevent leakage of the resin. To prepare the resin, we
mixed two types of glue (Araldite, Huntsman Advanced
Materials, Basel, Switzerland) in equal proportions (50/50 %). Afterwards, the resin was poured into the smaller
tube in which the humerus was placed, being careful to
support the other end of the supraspinatus complex
(scapula) to preserve the physiological angle between the
humerus and scapula. We then prepared the resin that
was poured into the larger tube, which contained the
scapula, in the same manner. The specimens were tested
parallel to the long axis of the SP tendon in their physio-
logical position using an Instron 5866 electromechanical
testing instrument. The velocity used during testing was
1.8 mm/min. The samples were loaded up to 10 N dur-
ing the test, unloaded to the initial point and then
loaded again until they reached the failure point. To esti-
mate the stiffness of the tendons, the tensile strength
machine registered the load [N] and displacement [mm].
The repaired stiffness was defined as the slope of the
load divided by the displacement at the failure point.
Failure was defined as the maximum value of the load
needed to permanently damage the sample.
Statistical analysis
Continuous variables were described using mean and
standard deviation (SD). To analyse the effect of the
different surgical treatments in the repaired tendons’
biomechanical capabilities (maximum load, stiffness
and deformity), a two-way ANOVA model was used,
introducing an interaction between such factor and
time (1, 2 and 3 months postinjury). Simple effects ana-
lysis, adjusted by Sidak’s method, was used to study
both the effects of time at each treatment level and the
effects of treatment at each time. Effects size was calcu-
lated using Cohen’s f.
A priori sample size calculation was performed using
G*Power (Heinrich-Heine-University Düsseldorf), assum-
ing that the interaction between time (1 and 3 month) and
the treatment (repair with OrthADAPT and MSCs) com-
pared with the use of suture had a large effect size (Cohen’s
f = 0.40), a two-tailed type I error of 0.05, and an 80 %
power. Based on such values, we would need a total sample
Tornero-Esteban et al. Journal of Orthopaedic Surgery and Research  (2015) 10:124 Page 4 of 7size of 52 animals. Also, a post hoc statistical power calcula-
tion was performed. Statistical analyses were performed
using STATA v12.
Results
Macroscopic examinations of the specimens
Gross examinations of the specimens at the time of dis-
section at 3 months after the repair treatment revealed
scar tissue around the healed area with inflammation
signs in all the study groups. Nevertheless, the signs of
inflammation were seen to be more prominent in ani-
mals treated with suture or collagen membrane in con-
trast with rats treated with MSCs. The treatment with
MSCs provided a clearer view of the repair area indica-
tive of a minor scar inflammatory condition (Fig. 2).
Different strategies for the repair of injured SP tendons
Biomechanical tests of the repaired SP tendons are sum-
marised in Table 1. With regard to maximum load, we ob-
served an almost significant interaction between treatment
and time (F = 2.62, df = 4, p = 0.053). Effect size for such
interaction was large (Cohen’s f = 0.41), and therefore, we
decided to perform simple effects analysis, despite this lack
of significance, to better characterise the relationship be-
tween both factors and their effect in maximum load.
When we analysed how this biomechanical capability chan-
ged with time for each treatment, we observed that repair
with OrthADAPT and MSCs was associated with a signifi-
cant increase in maximum load (p = 0.04), between months
1 and 3 (Table 2). On the other hand, when we compared
the different treatments among themselves at different time
points, we observed that the repair with OrthADAPT and
MSCs has associated with a significant higher maximum
load, when compared with the use of suture, but only at
3 months (p = 0.014) (Table 3). With regard to stiffness and
deformity, no significant interaction was observed (F = 1.68,
df = 4, p = 0.18; F = 0.40, df = 4, p = 0.81; respectively).Fig. 2 Macroscopic view of shoulders. a Normal shoulder. b Suture. c Sutu
mesenchymal stem cells. Black arrows represent the tendon-bone interfaceIn the post hoc statistical power calculation, based on
the observed results, our study achieved a 70 % power.
Discussion
Despite the great advances in the surgical procedures
used to treat rotator cuff tears, the frequency of re-
rupture is still unacceptable for large injuries. Although
the cause of this poor healing rate is not well known,
chronic degenerative lesions are most common in the
elderly, and the elevated tension to which the suture is
subjected makes determining the prognosis for healing
decidedly more complicated [5–7]. Therefore, the first
aim of this study was to develop an animal model to re-
produce, as much as possible, the conditions observed in
elderly patients who have rotator cuff tears. This model
had to take into account key aspects such as age, the
chronic nature of the injury and full-thickness injury to
the SP tendon. Once the model was established, our sec-
ond aim was to reproduce SP tendon detachment and
delayed repair to mimic the repair of chronic rotator cuff
tears in humans. We used three different repair strate-
gies—sutures and type I collagen membranes with or
without MSCs—to determine the most suitable treat-
ment for the repair of chronic rotator cuff tears.
Soslowsky’s group [9] have established rat models of
chronic rotator cuff tears; however, the biomechanical
properties of these models were not the same. Our rat
model, in which we detached the SP tendon, is similar to
that proposed by Soslowsky, but in contrast to the re-
sults for Soslowsky’s model, in the present study, the
failure to load and stiffness progressively decreased with
time postdetachment. This trend is most likely due to
the erratic formation of scar tissue adhesions and their
subsequent degradation over time.
Whereas most animal models have been developed in
young animals, the current study used older animals to
develop a chronic rotator cuff tear rat model in whichre plus collagen membrane. d Suture plus collagen membrane plus
Table 1 Biomechanical characteristics
n Suture mean (SD) n OrthADAPT mean (SD) n OrthADAPT + MSCs mean (SD)
Max. load
1 4 34.84 (6.96) 6 24.16 (15.81) 6 25.27 (9.96)
Time (months) 2 4 29.77 (10.81) 4 32,59 (15.65) 5 27.86 (11.1)
3 4 20.63 (11.69) 5 31.43 (6.97) 3 45.01 (1.84)
Deformation
1 4 7.5 (2.3) 6 6.13 (2.72) 6 10.08 (9.37)
Time (months) 2 4 10.08 (2.24) 4 8.92 (2.97) 5 7.92 (5.21)
3 3 8.01 (3.42) 5 7.82 (7.17) 4 7.9 (3.42)
Stiffness
1 4 4.83 (0.94) 6 3.03 (1.66) 6 2.58 (1.26)
Time (months) 2 4 3.03 (1.02) 4 5.33 (4.13) 5 2.82 (1.12)
3 3 2.63 (1.06) 5 5.56 (4.11) 4 4.45 (0.57)
Max. load maximum load, SD standard deviation, MSCs mesenchymal stem cells
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the lack of spontaneous healing. These results were con-
firmed by the presence of degenerative changes in the
surrounding tissue, such as adipose tissue infiltrating the
muscle, and mineral changes affecting the humeral head,
which were observed macroscopically during dissection.
Overall, our animal model showed decreased mechanical
functioning as well as degenerative histological changes
consistent with a chronic condition. The loss of strength
as time progressed after treatment mimics the long-term
high re-rupture rate observed in humans after treatment
with primary surgery.
The ability of the MSCs to improve the biomechanical
characteristics of the injured SP tendon compared with
the other two strategies was encouraging. While the
suture-treated animals showed a loss of biomechanical
functioning as time progressed, in the MSC-membrane
repair group, the maximum load to failure was statisti-
cally significantly improved at 3 months compared with
suture groups. This finding indicates that the animals
treated with MSCs have greater strength in the injured
SP in terms of the resistance to breakage, which is con-
sistent with the results of previous studies reporting
significant increases in biomechanical functioning after
implanting MSC collagen membranes in patellar tendon
defects [18].Table 2 Biomechanical characteristics
Suture OrthADAPT OrthADAPT + MSCs
2 vs. 1 month 0.89 0.57 0.97
3 vs. 1 month 0.21 0.64 0.04*
3 vs. 2 months 0.58 0.99 0.11
Maximum load by time
MSCs mesenchymal stem cells
*p < 0.05In summary, our study demonstrated that tendon
treatment with MSCs significantly improved the tendon’s
maximum load property and resulted in an augmented
remodelled appearance compared with the other two
methods at 3 months. It is possible that the healing
process in the healthy state of the tendon is slowed,
which could be explained by the animal model used in
this study. First, to mimic the repair of chronic rotator
cuff tears in humans, we began treatment in our animal
model 1 month after detachment. It is known that heal-
ing is worse under these conditions than in acute injur-
ies, although the reasons remain unclear. Second, MSCs
were obtained from aged animals, which possess a de-
creased natural healing capacity. Although the exact
mechanism responsible for the positive influence of
MSCs on tendon healing remains uncertain, it is well
known that MSCs have the capacity to differentiate into
tenocytes, possess the capability to release growth fac-
tors and exhibit anti-inflammatory effects [19] at the site
of injury, which could help provide a better healing
environment and eventually lead to the regeneration of
the damaged tissue.
Given the age of the rats used in the current study, the
MSC differentiation rate might be slower, or these cells
could even release growth factors in a slower manner
than MSCs isolated from younger animals. We thereforeTable 3 Biomechanical characteristics
1 month 2 months 3 months
OrthADAPT vs. suture 0.37 0.98 0.39
OrthADAPT + MSCs vs. suture 0.47 0.99 0.014*
OrthADAPT + MSCs vs. OrthADAPT 0.99 0.90 0.27
Maximum load by different approaches for the repair
MSCs mesenchymal stem cells
*p < 0.05
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over a longer treatment period and to assess MSCs iso-
lated from donors of various ages, especially in the case
of aged animals.
In a rotator cuff tear model developed in young ani-
mals, Gulotta et al. [20] reported that there was a lack of
differences with regard to the strength of the tendon and
the alignment of the tendon collagen fibres when the an-
imals were injected with MSCs compared with the
vehicle-injected controls at 1 month, but these re-
searchers neglected to evaluate the animals at later time
points. However, they reported an improvement in the
biomechanical and morphological properties in young
animals at 45 days after the injection of MSCs.
Our findings suggest that the therapeutic use of allo-
geneic MSCs in type I collagen membranes for the re-
pair of rotator cuff tears appears to be the most
promising treatment in the long term. Nevertheless,
questions concerning the optimal MSC dose, the effect-
ive time period, the optimal type of matrix material and
donor age remain unanswered and will need to be ad-
dressed in future studies. This knowledge will hopefully
lead to further advances that will improve the regener-
ation of injured SP tendons in the rotator cuff.Conclusions
Gross inspection of the specimens at the time of dis-
section revealed that the musculoskeletal unit was
stiff, and the tendon appeared to be retracted. Al-
though some studies using animal models have re-
ported that the tendon heals naturally after release,
producing a neotendon even in the absence of a sur-
gical procedure using sutures, the aged rats used as
our animal model retained the gap even at 3 months
after the infliction of the lesion. The introduction of
MSCs in the type I collagen membrane placed at the
site of the surgically created defects resulted in the
production of mechanically superior tissue, with im-
proved SP tendon strength and stiffness at 3 months
after treatment in comparison with the use of an
acellular collagen membrane or sutures. More work is
needed to determine the optimal matrix and dose of
MSCs. The improvement is most likely influenced by
mechanisms that affect the differentiation of MSCs
and by factors that control the inflammatory environ-
ment at the site of injury. The application of MSCs
to treat rotator cuff injuries may help improve the
functionality of the shoulder. Future studies will be
needed to test the effect of MSCs on tendon healing
over a prolonged period of time.Competing interests
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